Merck seems to have identified cytokines as a fertile ground for exploration, as the Synthekine deal follows its earlier $1.9 billion takeover of Pandion Therapeutics, which is developing a ...

The team with the most convincing innovative project ideas wins the Merck Innovation Cup along with a prize of €20,000. The best ideas may be implemented by Merck, with the opportunity to secure ...

Switzerland’s Debiopharm has announced a collaboration with Germany's Merck and Pfizer to evaluate Debio 1143, in combination with avelumab, in patients with advanced or metastatic non-small ...